Pioneering AI Drug Discovery | Recursion
Our data and the Recursion OS enable us to train intelligent machine learning models for AI drug discovery and development, which help us rapidly identify new targets and design highly optimized …
Our Unique Approach to AI Drug Discovery | Recursion
Recursion's TechBio approach: The future of AI drug discovery In traditional drug discovery, 90% of drugs fail in clinical trials, after more than a decade in development and ~$2 billion in costs. We’re …
Recursion's Drug Discovery Pipeline | Recursion
Explore Recursion's dynamic drug discovery pipeline. Witness the innovations and breakthroughs in our journey. Dive deeper with us today!
Recursion Reports Fourth Quarter and Full Year 2025 Financial Results ...
31 دسمبر، 2025 · SALT LAKE CITY, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported …
Technology - Recursion OS:
Central to our mission is the Recursion Operating System (OS), a platform powered by one of the world’s largest proprietary biological and chemical datasets. Instead of looking narrowly at a handful of …
Recursion Pharmaceuticals, Inc. - Press Releases
12 فروری، 2026 · The Investor Relations website contains information about Recursion Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
How a First-of-its-Kind “Microglia Map” from Recursion and Roche and ...
29 اکتوبر، 2025 · A first-of-its-kind whole genome map from researchers at Recursion with partners Roche and Genentech offers a new approach to exploring novel targets and pathways for a wide …
Meet our Team | Recursion
Get acquainted with the brilliant minds behind Recursion. Dive into our team's passion, expertise, and vision. Read more about our team today!
Recursion Announces Completion of NVIDIA-Powered BioHive-2, the …
13 مئی، 2024 · Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse …
Recursion Reports Second Quarter 2025 Financial Results and …
SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates …
مشمول پر چھوڑیں
قابل رسائی فیڈ بیک